The Trading Window of the Company shall remain closed with effect from January 1, 2026 until the expiry of 48 hours after the declaration of financial results for the quarter ended 31st December 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries has informed the BSE that its trading window will remain closed starting January 1, 2026, until 48 hours after the company declares its financial results for the quarter ended December 31, 2025 (Q3 FY26). This is a routine, mandatory compliance disclosure under SEBI's Insider Trading Regulations (Schedule B). During this period, directors, key managerial personnel, and designated insiders are prohibited from trading in the company's shares. The notice was signed by Nirav Shah, Company Secretary, on December 30, 2025.
This is a standard regulatory formality before quarterly results and does not indicate any positive or negative news. Investors should note that promoters and insiders cannot buy or sell shares during the closed window, and they typically time their result declaration within about 5-6 weeks of the quarter-end.